| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Feb―22 |
An Engineered SARS-CoV-2 S1 Glycoprotein Produced in Pichia pastoris as a Candidate Vaccine Antigen |
Sanaz Majidi, Khosrow Aghaiypour Kolyani, Meisam Akrami, Maryam Dadar |
| 2 |
[GO] |
2025―Jan―09 |
A Bibliometric Analysis on Multi-epitope Vaccine Development Against SARS-CoV-2: Current Status, Development, and Future Directions |
Kanwal Khalid, Fiaz Ahmad, Ayaz Anwar, Seng-Kai Ong |
| 3 |
[GO] |
2024―Nov―27 |
Mapping the Potential Genes and Associated Pathways Involved in Long COVID-Associated Brain Fog Using Integrative Bioinformatics and Systems Biology Strategy |
Chiranjib Chakraborty, Manojit Bhattacharya, Abdulrahman Alshammari, Norah A. Albekairi, Sang-Soo Lee |
| 4 |
[GO] |
2024―Oct―07 |
Exploring Niclosamide as a Multi-target Drug Against SARS-CoV-2: Molecular Dynamics Simulation Studies on Host and Viral Proteins |
Prachi Jagtap, Virendra Kumar Meena, Susmit Sambhare, Atanu Basu, Priya Abraham, Sarah Cherian |
| 5 |
[GO] |
2024―Oct―01 |
Glycoprofile Comparison of the SARS-CoV-2 Spike Proteins Expressed in CHO and HEK Cell Lines |
Helen L. Wright, Caroline Evans, Philip J. Jackson, David C. James, Kang Lan Tee, Tuck Seng Wong, Mark J. Dickman, Jagroop Pandhal |
| 6 |
[GO] |
2024―Sep―24 |
Development and Validation of a Highly Sensitive RT-qLAMP Assay for Rapid Detection of SARS-CoV-2: Methodological Aspects |
Faezeh Mahmoudi, Davod Jafari, Seyedeh Mona Mousavi Esfahani, Arshad Hoseini, Mahmood Barati, Neda Saraygord-Afshari |
| 7 |
[GO] |
2024―Sep―13 |
Angiotensin-Converting Enzyme-2 (ACE2) Downregulation During Coronavirus Infection |
Nurshamimi Nor Rashid, Lina Amrani, Abdullah Alwan, Zulqarnain Mohamed, Rohana Yusof, Hussin Rothan |
| 8 |
[GO] |
2024―Aug―23 |
In Silico Analysis of Calotropis procera-Derived Phytochemicals Targeting 3CL Proteoase of SARS-CoV-2 |
Tayyaba Shafique, Mohsin Javed, Muhammad Ali, Shahid Iqbal, Muhammad Faizan, Ammar Zidan, Ali Bahadur, Sajid Mahmood, Fadi Jaber, Khalid M. Alotaibi, Matar Alshalwi |
| 9 |
[GO] |
2024―Aug―01 |
Prospects of Innovative Therapeutics in Combating the COVID-19 Pandemic |
Thamby Rajah Mahendran, Binsin Cynthia, Ramesh Thevendran, Solayappan Maheswaran |
| 10 |
[GO] |
2024―May―04 |
Emerging Trends of Gold Nanostructures for Point-of-Care Biosensor-Based Detection of COVID-19 |
Akhilesh Kumar Yadav, Nagaraj Basavegowda, Saba Shirin, Shiji Raju, Rajkumar Sekar, Prathap Somu, U. T. Uthappa, Gholamreza Abdi |
| 11 |
[GO] |
2024―Apr―25 |
Development of Anti-idiotypic Monoclonal Antibody Mimicking SARS-CoV-2 Receptor Binding Domain |
Gamze Kılıç, Elif Demirkan, Fatıma Yücel |
| 12 |
[GO] |
2024―Apr―15 |
Prediction of Prospective Mutational Landscape of SARS-CoV-2 Spike ssRNA and Evolutionary Basis of Its Host Interaction |
Aniket Sarkar, Trijit Arka Ghosh, Bidyut Bandyopadhyay, Smarajit Maiti, Anindya Sundar Panja |
| 13 |
[GO] |
2024―Mar―08 |
Association Between Altered Microbiota Composition and Immune System-Related Genes in COVID-19 Infection |
Sara Ahmadi Badi, Arian Kariman, Ahmad Bereimipour, Shima Shojaie, Mohammadreza Aghsadeghi, Shohreh Khatami, Andrea Masotti |
| 14 |
[GO] |
2023―Nov―25 |
Immunogenicity and Protective Efficacy of Nucleic Acid-Based Vaccines Against COVID-19: A Systematic Review |
Dahiru Hafiz Karofi, Nafi’u Lawal, Muhammad Bashir Bello, Mustapha Umar Imam |
| 15 |
[GO] |
2023―Oct―25 |
Eicosanoids Signals in SARS-CoV-2 Infection: A Foe or Friend |
Mohammad Sharifur Rahman, Mohammad Salim Hossain |
| 16 |
[GO] |
2023―Jul―25 |
Screening of Potential Inhibitors Targeting the Main Protease Structure of SARS-CoV-2 via Molecular Docking, and Approach with Molecular Dynamics, RMSD, RMSF, H-Bond, SASA and MMGBSA |
Aluísio Marques da Fonseca, Bernardino Joaquim Caluaco, Junilson Martinho Canjanja Madureira, Sadrack Queque Cabongo, Eduardo Menezes Gaieta, Faustino Djata, Regilany Paulo Colares, Moises Maia Neto, Carla Freire Celedonio Fernandes, Gabrielle Silva Marinho, Hélcio Silva dos Santos, Emmanuel Silva Marinho |
| 17 |
[GO] |
2023―Apr―19 |
Development of Adenovirus-Based Covid-19 Vaccine Candidate in Indonesia |
Anita Artarini, Tia Hadianti, Ernawati Arifin Giri-Rachman, Marselina Irasonia Tan, Intan A. Safitri, Nurhamidah A. Hidayat, Debbie S. Retnoningrum, Dessy Natalia |
| 18 |
[GO] |
2023―Apr―15 |
Development of a Single-Chain Fragment Variable that Binds to the SARS-CoV-2 Spike Protein Produced by Genetically Modified Lactic Acid Bacteria |
Suzuka Oshima, Fu Namai, Takashi Sato, Takeshi Shimosato |
| 19 |
[GO] |
2023―Feb―13 |
Anticancer and Biological Effects of Some Natural Compounds and Theoretical Investigation of them Against RdRP of SARS-COV-2: In Silico and In Vitro Studies |
Jing Zhang, Jingyu Feng, Yang Li, Jiguo Wang, Panyan Mo, Changguo Luo |
| 20 |
[GO] |
2023―Feb―08 |
Identification of Pyrazole Derivatives of Usnic Acid as Novel Inhibitor of SARS-CoV-2 Main Protease Through Virtual Screening Approaches |
Miah Roney, Gagandeep Singh, A. K. M. Moyeenul Huq, Md Shaekh Forid, Wan Maznah Binti Wan Ishak, Kamal Rullah, Mohd Fadhlizil Fasihi Mohd Aluwi, Saiful Nizam Tajuddin |
| 21 |
[GO] |
2023―Jan―24 |
Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study |
Amgad M. Rabie, Wafa A. Eltayb |
| 22 |
[GO] |
2022―Dec―04 |
Structural Landscape of nsp Coding Genomic Regions of SARS-CoV-2-ssRNA Genome: A Structural Genomics Approach Toward Identification of Druggable Genome, Ligand-Binding Pockets, and Structure-Based Druggability |
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, Srijan Chatterjee, Govindasamy Agoramoorthy, Sang-Soo Lee |
| 23 |
[GO] |
2022―Oct―01 |
CRISPR-Based Diagnostics and Microfluidics for COVID-19 Point-of-Care Testing: A Review of Main Applications |
Fatemeh Nafian, Simin Nafian, Babak Kamali Doust Azad, Mehrdad Hashemi |
| 24 |
[GO] |
2022―Sep―14 |
Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay |
Termsak Tantiwiwat, Apisitt Thaiprayoon, Ake-kavitch Siriatcharanon, Chakrit Tachaapaikoon, Nongluk Plongthongkum, Dujduan Waraho-Zhmayev |
| 25 |
[GO] |
2022―Feb―01 |
The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Genome Editing |
Zeinab Yousefi Najafabadi, Songwe Fanuel, Reza Falak, Saeed Kaboli, Gholam Ali Kardar |
| 26 |
[GO] |
2022―Jan―04 |
Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach |
Manojit Bhattacharya, Ashish Ranjan Sharma, Pratik Ghosh, Prasanta Patra, Bidhan Chandra Patra, Sang-Soo Lee, Chiranjib Chakraborty |
| 27 |
[GO] |
2021―Oct―16 |
An Insight Into Detection Pathways/Biosensors of Highly Infectious Coronaviruses |
Mehrnaz Entesari, Mina Zamani, Mohammad Heidarizadeh, Rasoul Moradi, Fatemeh Khakdan, Fariba Rafiei |
| 28 |
[GO] |
2021―Aug―22 |
Evaluating Stability and Activity of SARS-CoV-2 PLpro for High-throughput Screening of Inhibitors |
Rimanshee Arya, Vishal Prashar, Mukesh Kumar |
| 29 |
[GO] |
2021―Aug―10 |
Correction to: Computational Lock and Key and Dynamic Trajectory Analysis of Natural Biophors Against COVID-19 Spike Protein to Identify Effective Lead Molecules |
Irfan Navabshan, Balasubramaniyan Sakthivel, Rajesh Pandiyan, Mariya Gover Antoniraj, Selvakumar Dharmaraj, Veeramuthu Ashokkumar, Kuan Shiong Khoo, Kit Wayne Chew, Abimanyu Sugumaran, Pau Loke Show |
| 30 |
[GO] |
2021―Jul―25 |
Production of scFv, Fab, and IgG of CR3022 Antibodies Against SARS-CoV-2 Using Silkworm-Baculovirus Expression System |
Takeru Ebihara, Akitsu Masuda, Daisuke Takahashi, Masato Hino, Hiroaki Mon, Kohei Kakino, Tsuguru Fujii, Ryosuke Fujita, Tadashi Ueda, Jae Man Lee, Takahiro Kusakabe |
| 31 |
[GO] |
2021―Jun―22 |
Computational Lock and Key and Dynamic Trajectory Analysis of Natural Biophors Against COVID-19 Spike Protein to Identify Effective Lead Molecules |
Irfan Navabshan, Balasubramaniyan Sakthivel, Rajesh Pandiyan, Mariya Gover Antoniraj, Selvakumar Dharmaraj, Veeramuthu Ashokkumar, Kuan Shiong Khoo, Kit Wayne Chew, Abimanyu Sugumaran, Pau Loke Show |
| 32 |
[GO] |
2021―Jun―18 |
COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era |
Ender Volkan |
| 33 |
[GO] |
2021―Feb―24 |
Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19 |
Seyed Mehdi Sadat, Mohammad Reza Aghadadeghi, Masoume Yousefi, Arezoo Khodaei, Mona Sadat Larijani, Golnaz Bahramali |
| 34 |
[GO] |
2021―Jan―19 |
Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro) |
Hussin A. Rothan, Teow Chong Teoh |
